AAAAAA

   
Results: 1-20 |
Results: 20

Authors: Andreassen, OA Meshul, CK Moore, C Jorgensen, HA
Citation: Oa. Andreassen et al., Oral dyskinesias and morphological changes in rat striatum during long-term haloperidol administration, PSYCHOPHAR, 157(1), 2001, pp. 11-19

Authors: Andreassen, OA Dedeoglu, A Ferrante, RJ Jenkins, BG Ferrante, KL Thomas, M Friedlich, A Browne, SE Schilling, G Borchelt, DR Hersch, SM Ross, CA Beal, MF
Citation: Oa. Andreassen et al., Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease, NEUROBIOL D, 8(3), 2001, pp. 479-491

Authors: Andreassen, OA Ferrante, RJ Dedeoglu, A Beal, MF
Citation: Oa. Andreassen et al., Lipoic acid improves survival in transgenic mouse models of Huntington's disease, NEUROREPORT, 12(15), 2001, pp. 3371-3373

Authors: Andreassen, OA Ferrante, RJ Huang, HM Dedeoglu, A Park, L Ferrante, KL Kwon, J Borchelt, DR Ross, CA Gibson, GE Beal, MF
Citation: Oa. Andreassen et al., Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's disease, ANN NEUROL, 50(1), 2001, pp. 112-117

Authors: Andreassen, OA Jenkins, BG Dedeoglu, A Ferrante, KL Bogdanov, MB Kaddurah-Daouk, R Beal, MF
Citation: Oa. Andreassen et al., Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation, J NEUROCHEM, 77(2), 2001, pp. 383-390

Authors: Andreassen, OA Ferrante, RJ Klivenyi, P Klein, AM Dedeoglu, A Albers, DS Kowall, NW Beal, MF
Citation: Oa. Andreassen et al., Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid, EXP NEUROL, 168(2), 2001, pp. 356-363

Authors: Andreassen, OA Dedeoglu, A Friedlich, A Ferrante, KL Hughes, D Szabo, C Beal, MF
Citation: Oa. Andreassen et al., Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice, EXP NEUROL, 168(2), 2001, pp. 419-424

Authors: Andreassen, OA Ferrante, RJ Dedeoglu, A Albers, DW Klivenyi, P Carlson, EJ Epstein, CJ Beal, MF
Citation: Oa. Andreassen et al., Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP, EXP NEUROL, 167(1), 2001, pp. 189-195

Authors: Klivenyi, P Andreassen, OA Ferrante, RJ Lancelot, E Reif, D Beal, MF
Citation: P. Klivenyi et al., Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity, NEUROREPORT, 11(6), 2000, pp. 1265-1268

Authors: Andreassen, OA Dedeoglu, A Klivenyi, P Beal, MF Bush, AI
Citation: Oa. Andreassen et al., N-acetyl-L-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis, NEUROREPORT, 11(11), 2000, pp. 2491-2493

Authors: Andreassen, OA Ferrante, RJ Klivenyi, P Klein, AM Shinobu, LA Epstein, CJ Beal, MF
Citation: Oa. Andreassen et al., Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis, ANN NEUROL, 47(4), 2000, pp. 447-455

Authors: Andreassen, OA Finsen, B Ostergaard, K West, MJ Jorgensen, HA
Citation: Oa. Andreassen et al., Reduced number of striatal neurons expressing preprosomatostatin mRNA in rats with oral dyskinesias after long-term haloperidol administration, NEUROSCI L, 279(1), 2000, pp. 21-24

Authors: Andreassen, OA Jorgensen, HA
Citation: Oa. Andreassen et Ha. Jorgensen, Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats- Implications for tardive dyskinesia?, PROG NEUROB, 61(5), 2000, pp. 525-541

Authors: Ferrante, RJ Andreassen, OA Jenkins, BG Dedeoglu, A Kuemmerle, S Kubilus, JK Kaddurah-Daouk, R Hersch, SM Beal, MF
Citation: Rj. Ferrante et al., Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease, J NEUROSC, 20(12), 2000, pp. 4389-4397

Authors: Klivenyi, P Andreassen, OA Ferrante, RJ Dedeoglu, A Mueller, G Lancelot, E Bogdanov, M Andersen, JK Jiang, DM Beal, MF
Citation: P. Klivenyi et al., Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, J NEUROSC, 20(1), 2000, pp. 1-7

Authors: Andreassen, OA Ferrante, RJ Hughes, DB Klivenyi, P Dedeoglu, A Ona, VO Friedlander, RM Beal, MF
Citation: Oa. Andreassen et al., Malonate and 3-nitropropionic acid neurotoxicity are reduced in transgenicmice expressing a caspase-1 dominant-negative mutant, J NEUROCHEM, 75(2), 2000, pp. 847-852

Authors: Jenkins, BG Klivenyi, P Kustermann, E Andreassen, OA Ferrante, RJ Rosen, BR Beal, MF
Citation: Bg. Jenkins et al., Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice, J NEUROCHEM, 74(5), 2000, pp. 2108-2119

Authors: Petersen, R Finsen, B Andreassen, OA Zimmer, J Jorgensen, HA
Citation: R. Petersen et al., No changes in dopamine D-1 receptor mRNA expressing neurons in the dorsal striatum of rats with oral movements induced by long-term haloperidol administration, BRAIN RES, 859(2), 2000, pp. 394-397

Authors: Klivenyi, P Ferrante, RJ Matthews, RT Bogdanov, MB Klein, AM Andreassen, OA Mueller, G Wermer, M Kaddurah-Daouk, R Beal, MF
Citation: P. Klivenyi et al., Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis, NAT MED, 5(3), 1999, pp. 347-350

Authors: Andreassen, OA Weber, C Jorgensen, HA
Citation: Oa. Andreassen et al., Coenzyme Q10 does not prevent oral dyskinesias induced by long-term haloperidol treatment of rats, PHARM BIO B, 64(3), 1999, pp. 637-642
Risultati: 1-20 |